Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CACI INTERNATIONAL INC /DE/CACI · Entity 3388 | Director | October 11, 2026 | October 14, 2026 |
| SENSIENT TECHNOLOGIES CORPSXT · Entity 3822 | Director | April 23, 2026 | April 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CACI INTERNATIONAL INC /DE/
Report date October 11, 2026 · Filed October 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CACI Common StockSEC Table I · non-derivative | Direct | 669 |
Reported balance
After 2026-10-11 transaction · row 1
1 source rowRow 1 · 2026-10-11 · Exercise / conversion · Acquired 85 · Balance 669 F1: On October 16, 2025, Mr. Morrison was granted 338 Restricted Stock Units that vest according to the following schedule: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-10-11 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-10-11 · Exercise / conversion · Disposed 85 · Balance 0 F1: On October 16, 2025, Mr. Morrison was granted 338 Restricted Stock Units that vest according to the following schedule: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 16, 2025, Mr. Morrison was granted 338 Restricted Stock Units that vest according to the following schedule: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
SENSIENT TECHNOLOGIES CORP
Report date April 23, 2026 · Filed April 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,546.476 |
Last balance in matching sequence
After 2026-04-23 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-04-23 · Grant · Acquired 1,119 · Balance 12,220.476 F1: Represents grant of restricted stock under Issuer's 2017 Stock Plan, as amended and restated. F2: Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. Row 2 · 2026-04-23 · Tax withholding · Disposed 674 · Balance 11,546.476 F3: Shares were withheld to cover tax withholding in connection with the vesting of prior restricted stock grant. F2: Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents grant of restricted stock under Issuer's 2017 Stock Plan, as amended and restated.
F2: Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.
F3: Shares were withheld to cover tax withholding in connection with the vesting of prior restricted stock grant.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BALL Corp
Report date September 25, 2023 · Filed September 25, 2023
Section 16 reporting ended · disclosed 2023-09-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 440,476.742 |
Reported balance
Holding disclosure · report date 2023-09-25 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 440,476.742 F1: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2023 Proxy Statement. |
| Common StockSEC Table I · non-derivative | Indirect401(k) Plan | 8,703.123 |
Reported balance
Holding disclosure · report date 2023-09-25 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 8,703.123 F1: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2023 Proxy Statement. F2: Total number of 401(k) Plan shares acquired through periodic dividend reinvestment, participant's contributions and employer matching contributions. |
| Common StockSEC Table I · non-derivative | IndirectTrust | 102,570 |
Reported balance
Holding disclosure · report date 2023-09-25 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 102,570 F1: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2023 Proxy Statement. |
| Common StockSEC Table I · non-derivative | IndirectBy Son | 100 |
Reported balance
Holding disclosure · report date 2023-09-25 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 100 F1: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2023 Proxy Statement. F3: The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest. |
| Deferred Compensation Company Stock PlanSEC Table II · derivative / convertible security | Direct | 239,869.9902 |
Reported balance
Holding disclosure · report date 2023-09-25 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 239,869.9902 F4: Each unit may be settled for a single share of stock or the equivalent amount of cash pursuant to the Ball Corporation Deferred Compensation Company Stock Plan. F5: Stock units in Ball Corporation's Deferred Compensation Company Stock Plan are distributed upon the separation of service in accordance with the plan. F1: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2023 Proxy Statement. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 29,548 |
Reported balance
Holding disclosure · report date 2023-09-25 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 29,548 F6: Each restricted stock unit represents a contingent right to receive one share of Ball Corporation Common Stock. F1: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2023 Proxy Statement. |
| Stock Appreciation Rights (sars)SEC Table II · derivative / convertible security · Conversion / exercise price $24.54 · Expires 2024-01-29 | Direct | 84,400 |
Reported balance
Holding disclosure · report date 2023-09-25 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 84,400 F1: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2023 Proxy Statement. |
| Stock Appreciation Rights (sars)SEC Table II · derivative / convertible security · Conversion / exercise price $33.08 · Expires 2025-02-04 | Direct | 70,422 |
Reported balance
Holding disclosure · report date 2023-09-25 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 70,422 F1: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2023 Proxy Statement. |
| Stock Appreciation Rights (sars)SEC Table II · derivative / convertible security · Conversion / exercise price $33.05 · Expires 2026-01-27 | Direct | 57,702 |
Reported balance
Holding disclosure · report date 2023-09-25 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 57,702 F1: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2023 Proxy Statement. |
| Stock Appreciation Rights (sars)SEC Table II · derivative / convertible security · Conversion / exercise price $38.38 · Expires 2027-01-25 | Direct | 67,916 |
Reported balance
Holding disclosure · report date 2023-09-25 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 67,916 F1: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2023 Proxy Statement. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.84 · Expires 2028-01-24 | Direct | 70,562 |
Reported balance
Holding disclosure · report date 2023-09-25 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 70,562 F1: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2023 Proxy Statement. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $50.78 · Expires 2029-01-23 | Direct | 54,785 |
Reported balance
Holding disclosure · report date 2023-09-25 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 54,785 F1: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2023 Proxy Statement. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $72.59 · Expires 2030-01-29 | Direct | 44,271 |
Reported balance
Holding disclosure · report date 2023-09-25 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 44,271 F1: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2023 Proxy Statement. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $85.33 · Expires 2031-01-27 | Direct | 36,465 |
Reported balance
Holding disclosure · report date 2023-09-25 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 36,465 F1: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2023 Proxy Statement. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $86.57 · Expires 2032-01-26 | Direct | 33,349 |
Reported balance
Holding disclosure · report date 2023-09-25 · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · Balance 33,349 F1: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2023 Proxy Statement. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $56.64 · Expires 2033-01-25 | Direct | 42,596 |
Reported balance
Holding disclosure · report date 2023-09-25 · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · Balance 42,596 F1: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2023 Proxy Statement. |
Filing footnotes · ownership attribution and instrument terms
F1: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2023 Proxy Statement.
F2: Total number of 401(k) Plan shares acquired through periodic dividend reinvestment, participant's contributions and employer matching contributions.
F3: The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.
F4: Each unit may be settled for a single share of stock or the equivalent amount of cash pursuant to the Ball Corporation Deferred Compensation Company Stock Plan.
F5: Stock units in Ball Corporation's Deferred Compensation Company Stock Plan are distributed upon the separation of service in accordance with the plan.
F6: Each restricted stock unit represents a contingent right to receive one share of Ball Corporation Common Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 11, 2026 Filed Oct 14, 2026 11:24 UTC | CACI INTERNATIONAL INC /DE/ CACI · Entity 3388 | Exercise / conversionRestricted Stock Units · Derivative | 85 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001205945-26-000004 · wk-form4_1791977064.xml · derivative · entry 2 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: CACI Common Stock · 85 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 16, 2025, Mr. Morrison was granted 338 Restricted Stock Units that vest according to the following schedule: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · price: On October 16, 2025, Mr. Morrison was granted 338 Restricted Stock Units that vest according to the following schedule: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.exercise_date: On October 16, 2025, Mr. Morrison was granted 338 Restricted Stock Units that vest according to the following schedule: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.expiration_date: On October 16, 2025, Mr. Morrison was granted 338 Restricted Stock Units that vest according to the following schedule: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| October 11, 2026 Filed Oct 14, 2026 11:24 UTC | CACI INTERNATIONAL INC /DE/ CACI · Entity 3388 | Exercise / conversionCACI Common Stock | 85 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001205945-26-000004 · wk-form4_1791977064.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 16, 2025, Mr. Morrison was granted 338 Restricted Stock Units that vest according to the following schedule: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| July 13, 2026 Filed Jul 15, 2026 10:43 UTC | CACI INTERNATIONAL INC /DE/ CACI · Entity 3388 | Exercise / conversionRestricted Stock Units · Derivative | 85 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001205945-26-000001 · wk-form4_1784112233.xml · derivative · entry 2 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85 Underlying: CACI Common Stock · 85 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 16, 2025, Mr. Morrison was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · price: On October 16, 2025, Mr. Morrison was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.exercise_date: On October 16, 2025, Mr. Morrison was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.expiration_date: On October 16, 2025, Mr. Morrison was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| July 13, 2026 Filed Jul 15, 2026 10:43 UTC | CACI INTERNATIONAL INC /DE/ CACI · Entity 3388 | Exercise / conversionCACI Common Stock | 85 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001205945-26-000001 · wk-form4_1784112233.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 16, 2025, Mr. Morrison was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 16:05 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | Tax withholdingCommon Stock | 674 | $99.23 | $66,881.02 |
DisclosureSEC source: 0000310142-26-000029 · form4.xml · nonDerivative · entry 2 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,546.476 F3 · kind: Shares were withheld to cover tax withholding in connection with the vesting of prior restricted stock grant. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. Read SEC document |
| April 23, 2026 Filed Apr 27, 2026 16:05 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantCommon Stock | 1,119 | $0.00 | $0.00 |
DisclosureSEC source: 0000310142-26-000029 · form4.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,220.476 F1 · kind: Represents grant of restricted stock under Issuer's 2017 Stock Plan, as amended and restated. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. Read SEC document |
| April 14, 2026 Filed Apr 16, 2026 19:29 UTC | CACI INTERNATIONAL INC /DE/ CACI · Entity 3388 | Exercise / conversionRestricted Stock Units · Derivative | 84 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-025471 · wk-form4_1776367792.xml · derivative · entry 2 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170 Underlying: CACI Common Stock · 84 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 17, 2025, Scott C .Morrison, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · price: On October 17, 2025, Scott C .Morrison, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.exercise_date: On October 17, 2025, Scott C .Morrison, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.expiration_date: On October 17, 2025, Scott C .Morrison, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| April 14, 2026 Filed Apr 16, 2026 19:29 UTC | CACI INTERNATIONAL INC /DE/ CACI · Entity 3388 | Exercise / conversionCACI Common Stock | 84 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-025471 · wk-form4_1776367792.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 499 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 17, 2025, Scott C .Morrison, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 19:44 UTC | CACI INTERNATIONAL INC /DE/ CACI · Entity 3388 | Exercise / conversionRestricted Stock Units · Derivative | 84 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-002344 · wk-form4_1768592690.xml · derivative · entry 2 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254 Underlying: CACI Common Stock · 84 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 17, 2025,Scott C .Morrison, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · price: On October 17, 2025,Scott C .Morrison, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.exercise_date: On October 17, 2025,Scott C .Morrison, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.expiration_date: On October 17, 2025,Scott C .Morrison, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 19:44 UTC | CACI INTERNATIONAL INC /DE/ CACI · Entity 3388 | Exercise / conversionCACI Common Stock | 84 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-002344 · wk-form4_1768592690.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 415 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 17, 2025,Scott C .Morrison, was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| October 16, 2025 Filed Oct 20, 2025 21:31 UTC | CACI INTERNATIONAL INC /DE/ CACI · Entity 3388 | GrantRestricted Stock Units · Derivative | 338 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001205945-25-000006 · wk-form4_1760995894.xml · derivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338 Underlying: CACI Common Stock · 338 shares Expires not disclosed F1 · derivative.exercise_price: On October 16, 2025, Mr. Morrison was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · price: On October 16, 2025, Mr. Morrison was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.exercise_date: On October 16, 2025, Mr. Morrison was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. F1 · derivative.expiration_date: On October 16, 2025, Mr. Morrison was granted 338 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 84 shares will vest on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Read SEC document |
| October 12, 2025 Filed Oct 14, 2025 21:24 UTC | CACI INTERNATIONAL INC /DE/ CACI · Entity 3388 | Exercise / conversionRestricted Stock Units · Derivative | 83 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001205945-25-000005 · wk-form4_1760477039.xml · derivative · entry 2 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: CACI Common Stock · 83 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · price: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · derivative.exercise_date: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · derivative.expiration_date: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. Read SEC document |
| October 12, 2025 Filed Oct 14, 2025 21:24 UTC | CACI INTERNATIONAL INC /DE/ CACI · Entity 3388 | Exercise / conversionCACI Common Stock | 83 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001205945-25-000005 · wk-form4_1760477039.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. Read SEC document |
| July 14, 2025 Filed Jul 16, 2025 20:39 UTC | CACI INTERNATIONAL INC /DE/ CACI · Entity 3388 | Exercise / conversionRestricted Stock Units · Derivative | 83 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-035099 · wk-form4_1752698314.xml · derivative · entry 2 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83 Underlying: CACI Common Stock · 83 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · price: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · derivative.exercise_date: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · derivative.expiration_date: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. Read SEC document |
| July 14, 2025 Filed Jul 16, 2025 20:39 UTC | CACI INTERNATIONAL INC /DE/ CACI · Entity 3388 | Exercise / conversionCACI Common Stock | 83 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-035099 · wk-form4_1752698314.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 248 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. Read SEC document |
| April 24, 2025 Filed Apr 28, 2025 18:12 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | Tax withholdingCommon Stock | 619 | $80.14 | $49,606.66 |
DisclosureSEC source: 0001127602-25-012670 · form4.xml · nonDerivative · entry 2 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,922.626 F3 · kind: Shares were withheld to cover tax withholding in connection with the vesting of a prior restricted stock grant. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. Read SEC document |
| April 24, 2025 Filed Apr 28, 2025 18:12 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantCommon Stock | 1,386 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-012670 · form4.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,541.626 F1 · kind: Represents grant of restricted stock under Issuer's 2017 Stock Plan, as amended and restated. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. Read SEC document |
| April 15, 2025 Filed Apr 17, 2025 20:01 UTC | CACI INTERNATIONAL INC /DE/ CACI · Entity 3388 | Exercise / conversionRestricted Stock Units · Derivative | 83 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-018197 · wk-form4_1744920065.xml · derivative · entry 2 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166 Underlying: CACI Common Stock · 83 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · price: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · derivative.exercise_date: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · derivative.expiration_date: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. Read SEC document |
| April 15, 2025 Filed Apr 17, 2025 20:01 UTC | CACI INTERNATIONAL INC /DE/ CACI · Entity 3388 | Exercise / conversionCACI Common Stock | 83 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-018197 · wk-form4_1744920065.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 21:53 UTC | CACI INTERNATIONAL INC /DE/ CACI · Entity 3388 | Exercise / conversionRestricted Stock Units · Derivative | 82 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000016058-25-000018 · wk-form4_1737150816.xml · derivative · entry 2 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249 Underlying: CACI Common Stock · 82 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares will vest on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · price: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares will vest on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · derivative.exercise_date: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares will vest on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · derivative.expiration_date: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares will vest on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 21:53 UTC | CACI INTERNATIONAL INC /DE/ CACI · Entity 3388 | Exercise / conversionCACI Common Stock | 82 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000016058-25-000018 · wk-form4_1737150816.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that vest according to the following vesting schedule: 82 shares will vest on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. Read SEC document |
| October 17, 2024 Filed Oct 28, 2024 17:24 UTC | CACI INTERNATIONAL INC /DE/ CACI · Entity 3388 | GrantRestricted Stock Units · Derivative | 331 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000016058-24-000204 · wk-form4_1730136281.xml · derivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331 Underlying: CACI Common Stock · 331 shares Expires not disclosed F1 · derivative.exercise_price: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 82 shares will vest on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · price: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 82 shares will vest on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · derivative.exercise_date: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 82 shares will vest on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. F1 · derivative.expiration_date: On October 17, 2024, Mr. Morrison was granted 331 Restricted Stock Units (RSUs) that will vest according to the following vesting schedule: 82 shares will vest on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025. Read SEC document |
| April 25, 2024 Filed Apr 29, 2024 15:59 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | Tax withholdingCommon Stock | 271 | $69.64 | $18,872.44 |
DisclosureSEC source: 0001127602-24-013513 · form4.xml · nonDerivative · entry 2 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,937.08 F3 · kind: Shares were withheld to cover tax withholding in connection with the vesting of prior restricted stock grant. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. Read SEC document |
| April 25, 2024 Filed Apr 29, 2024 15:59 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantCommon Stock | 1,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-013513 · form4.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,208.08 F1 · kind: Represents grant of restricted stock under Issuer's 2017 Stock Plan, as amended and restated. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. Read SEC document |
| April 27, 2023 Filed May 1, 2023 15:58 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | Tax withholdingCommon Stock | 561 | $73.70 | $41,345.70 |
DisclosureSEC source: 0001127602-23-013851 · form4.xml · nonDerivative · entry 2 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,554.057 F3 · kind: Shares were withheld to cover tax withholding in connection with the vesting of prior restricted stock grant. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan and Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. Read SEC document |
| April 27, 2023 Filed May 1, 2023 15:58 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantCommon Stock | 1,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-013851 · form4.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,115.057 F1 · kind: Represents grant of restricted stock under Issuer's 2017 Stock Plan, as amended and restated. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan and Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. Read SEC document |
| January 25, 2023 Filed Jan 28, 2023 00:10 UTC | BALL Corp BALL · Entity 3320 | GrantStock Option (Right to Buy) · Derivative | 42,596 | $0.00 Strike: $56.64 | $0.00 |
DisclosureSEC source: 0001062993-23-001531 · form4.xml · derivative · entry 2 MORRISON SCOTT C · CIK 0001205945 · E.V.P. and C.F.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,596 Underlying: Common Stock · 42,596 shares Expires 2033-01-25 F4 · kind: Non-Qualified Stock Options Granted under the Ball Corporation Stock and Cash Incentive Plan. F3 · ownership.direct: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2022 Proxy Statement. Read SEC document |
| January 25, 2023 Filed Jan 28, 2023 00:10 UTC | BALL Corp BALL · Entity 3320 | GrantRestricted Stock Units · Derivative | 12,747 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-001531 · form4.xml · derivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · E.V.P. and C.F.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,916 Underlying: Common Stock · 12,747 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Ball Corporation Common Stock. F2 · kind: Restricted Stock Units awarded under the Ball Corporation Stock and Cash Incentive Plan. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Ball Corporation Common Stock. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Ball Corporation Common Stock. F3 · ownership.direct: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2022 Proxy Statement. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 01:46 UTC | BALL Corp BLL · Entity 3320 | PurchaseCommon Stock | 17,500 | $57.59 | $1,007,762.00 |
DisclosureSEC source: 0001062993-22-017598 · form4.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · E.V.P. and C.F.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,102.3031 F1 · price: This transaction was executed in multiple trades at prices ranging from $57.54 to $57.605. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.direct: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2022 Proxy Statement. Read SEC document |
| April 28, 2022 Filed May 2, 2022 22:20 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantCommon Stock | 1,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012898 · form4.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,730.586 F1 · kind: Represents grant of restricted stock under Issuer's 2017 Stock Plan, as amended and restated. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan. Read SEC document |
| January 31, 2022 Filed Feb 3, 2022 00:32 UTC | BALL Corp BLL · Entity 3320 | Exercise / conversionRestricted Stock Units · Derivative | 13,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-002322 · form4.xml · derivative · entry 6 MORRISON SCOTT C · CIK 0001205945 · E.V.P. and C.F.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,169 Underlying: Common Stock · 13,076 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Ball Corporation Common Stock. F6 · kind: Lapse of restrictions on Performance Contingent Restricted Stock Units as a result of attainment of the performance criteria. F6 · derivative.exercise_date: Lapse of restrictions on Performance Contingent Restricted Stock Units as a result of attainment of the performance criteria. F6 · derivative.expiration_date: Lapse of restrictions on Performance Contingent Restricted Stock Units as a result of attainment of the performance criteria. F2 · ownership.direct: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2021 Proxy Statement. Read SEC document |
| January 31, 2022 Filed Feb 3, 2022 00:32 UTC | BALL Corp BLL · Entity 3320 | Tax withholdingCommon Stock | 7,438 | $97.10 | $722,229.80 |
DisclosureSEC source: 0001062993-22-002322 · form4.xml · nonDerivative · entry 2 MORRISON SCOTT C · CIK 0001205945 · E.V.P. and C.F.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,137.1776 F3 · shares: Shares withheld for the payment of the tax obligation on the lapse of restrictions on Table II Restricted Stock Units. F2 · ownership.direct: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2021 Proxy Statement. Read SEC document |
| January 31, 2022 Filed Feb 3, 2022 00:32 UTC | BALL Corp BLL · Entity 3320 | Exercise / conversionCommon Stock | 20,360 | $97.10 | $1,976,956.00 |
DisclosureSEC source: 0001062993-22-002322 · form4.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · E.V.P. and C.F.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 402,575.1776 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Common stock acquired upon the lapse of Table II Performance Contingent Restricted Stock Units based on the applicable Ball Corporation Stock and Cash Incentive Plan performance factor and in accordance with the provisions of said Plan. F2 · ownership.direct: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2021 Proxy Statement. Read SEC document |
| January 26, 2022 Filed Jan 29, 2022 00:01 UTC | BALL Corp BLL · Entity 3320 | GrantStock Option (Right to Buy) · Derivative | 33,349 | $0.00 Strike: $86.57 | $0.00 |
DisclosureSEC source: 0001062993-22-001805 · form4.xml · derivative · entry 2 MORRISON SCOTT C · CIK 0001205945 · E.V.P. and C.F.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,349 Underlying: Common Stock · 33,349 shares Expires 2032-01-26 F4 · kind: Non- Qualified Stock Options Granted under the Ball Corporation Stock and Cash Incentive Plan. F3 · ownership.direct: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2021 Proxy Statement. Read SEC document |
| January 26, 2022 Filed Jan 29, 2022 00:01 UTC | BALL Corp BLL · Entity 3320 | GrantRestricted Stock Units · Derivative | 8,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-001805 · form4.xml · derivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · E.V.P. and C.F.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,245 Underlying: Common Stock · 8,340 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Ball Corporation Common Stock. F2 · kind: Restricted Stock Units awarded under the Ball Corporation Stock and Cash Incentive Plan. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Ball Corporation Common Stock. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Ball Corporation Common Stock. F3 · ownership.direct: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2021 Proxy Statement. Read SEC document |
| December 06, 2021 Filed Dec 9, 2021 00:07 UTC | BALL Corp BLL · Entity 3320 | GiftCommon Stock | 5,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-012465 · form4.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · E.V.P. and C.F.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 382,024.781 F1 · shares: Mr. Morrison transferred these shares to a charitable foundation. There is no change in the voting rights for these shares associated with this transaction. F2 · ownership.direct: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2021 Proxy Statement. Read SEC document |
| November 16, 2021 Filed Nov 18, 2021 22:56 UTC | BALL Corp BLL · Entity 3320 | GiftCommon Stock | 5,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-011157 · form4.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · E.V.P. and C.F.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,337.862 F1 · shares: Mr. Morrison transferred these shares to a charitable foundation. There is no change in the voting rights for these shares associated with this transaction. F2 · ownership.direct: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2021 Proxy Statement. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 22:50 UTC | BALL Corp BLL · Entity 3320 | Exercise / conversionStock Appreciation Rights (sars) · Derivative | 21,100 | $0.00 Strike: $22.97 | $0.00 |
DisclosureSEC source: 0000009389-21-000179 · edgar.xml · derivative · entry 6 MORRISON SCOTT C · CIK 0001205945 · E.V.P. and C.F.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,100 shares Expires 2023-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: Exercise of Stock Appreciation Rights (SARS) pursuant to reporting person's December 4, 2020 10b5- 1 Plan. F2 · ownership.direct: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2021 Proxy Statement. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 22:50 UTC | BALL Corp BLL · Entity 3320 | Tax withholdingCommon Stock | 12,180 | $93.21 | $1,135,297.80 |
DisclosureSEC source: 0000009389-21-000179 · edgar.xml · nonDerivative · entry 2 MORRISON SCOTT C · CIK 0001205945 · E.V.P. and C.F.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 392,575.1909 F3 · kind: Shares withheld for the cost of the Stock Appreciation Rights (SARS) and for payment of the tax obligation on the exercise of the Table II SARS. F2 · ownership.direct: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2021 Proxy Statement. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 22:50 UTC | BALL Corp BLL · Entity 3320 | Exercise / conversionCommon Stock | 21,100 | $22.97 | $484,561.50 |
DisclosureSEC source: 0000009389-21-000179 · edgar.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · E.V.P. and C.F.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404,755.1909 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common stock acquired upon the exercise of Stock Appreciation Rights (SARS). F2 · ownership.direct: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2021 Proxy Statement. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 23:00 UTC | BALL Corp BLL · Entity 3320 | Exercise / conversionStock Option (Right to Buy) · Derivative | 800 | $0.00 Strike: $18.85 | $0.00 |
DisclosureSEC source: 0000009389-21-000140 · edgar.xml · derivative · entry 6 MORRISON SCOTT C · CIK 0001205945 · E.V.P. and C.F.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 800 shares Expires 2022-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · ownership.direct: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2021 Proxy Statement. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 23:00 UTC | BALL Corp BLL · Entity 3320 | Tax withholdingCommon Stock | 169 | $89.39 | $15,106.91 |
DisclosureSEC source: 0000009389-21-000140 · edgar.xml · nonDerivative · entry 2 MORRISON SCOTT C · CIK 0001205945 · E.V.P. and C.F.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 383,499.2563 F4 · shares: Option exercise cost was covered through a stock swap transaction. F3 · ownership.direct: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2021 Proxy Statement. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 23:00 UTC | BALL Corp BLL · Entity 3320 | Exercise / conversionCommon Stock | 800 | $18.85 | $15,080.00 |
DisclosureSEC source: 0000009389-21-000140 · edgar.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · E.V.P. and C.F.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 383,668.2563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise of Incentive Stock Options (ISOs). F2 · balance_after: 18,772 of these shares were previously reported as owned by the reporting person's trust but were transferred to the reporting person on August 9, 2021. F3 · ownership.direct: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2021 Proxy Statement. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 20:33 UTC | BALL Corp BLL · Entity 3320 | Exercise / conversionStock Appreciation Rights (sars) · Derivative | 21,100 | $0.00 Strike: $22.97 | $0.00 |
DisclosureSEC source: 0000009389-21-000118 · edgar.xml · derivative · entry 6 MORRISON SCOTT C · CIK 0001205945 · E.V.P. and C.F.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,100 Underlying: Common Stock · 21,100 shares Expires 2023-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: Exercise of Stock Appreciation Rights (SARS) pursuant to reporting person's December 4, 2020 10b5- 1 Plan. F2 · ownership.direct: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2021 Proxy Statement. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 20:33 UTC | BALL Corp BLL · Entity 3320 | Tax withholdingCommon Stock | 12,464 | $84.94 | $1,058,692.16 |
DisclosureSEC source: 0000009389-21-000118 · edgar.xml · nonDerivative · entry 2 MORRISON SCOTT C · CIK 0001205945 · E.V.P. and C.F.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,089.736 F3 · kind: Shares withheld for the cost of the Stock Appreciation Rights (SARS) and for payment of the tax obligation on the exercise of the Table II SARS. F2 · ownership.direct: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2021 Proxy Statement. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 20:33 UTC | BALL Corp BLL · Entity 3320 | Exercise / conversionCommon Stock | 21,100 | $22.97 | $484,561.50 |
DisclosureSEC source: 0000009389-21-000118 · edgar.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · E.V.P. and C.F.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376,553.736 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common stock acquired upon the exercise of Stock Appreciation Rights (SARS). F2 · ownership.direct: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2021 Proxy Statement. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:45 UTC | BALL Corp BLL · Entity 3320 | Exercise / conversionStock Appreciation Rights (sars) · Derivative | 21,100 | $0.00 Strike: $22.97 | $0.00 |
DisclosureSEC source: 0000009389-21-000106 · edgar.xml · derivative · entry 6 MORRISON SCOTT C · CIK 0001205945 · E.V.P. and C.F.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,200 Underlying: Common Stock · 21,100 shares Expires 2023-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: Exercise of Stock Appreciation Rights (SARS) pursuant to reporting person's December 4, 2020 10b5- 1 Plan. F2 · ownership.direct: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2021 Proxy Statement. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:45 UTC | BALL Corp BLL · Entity 3320 | Tax withholdingCommon Stock | 12,314 | $89.10 | $1,097,177.40 |
DisclosureSEC source: 0000009389-21-000106 · edgar.xml · nonDerivative · entry 2 MORRISON SCOTT C · CIK 0001205945 · E.V.P. and C.F.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,293.0751 F3 · kind: Shares withheld for the cost of the Stock Appreciation Rights (SARS) and for payment of the tax obligation on the exercise of the Table II SARS. F2 · ownership.direct: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2021 Proxy Statement. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:45 UTC | BALL Corp BLL · Entity 3320 | Exercise / conversionCommon Stock | 21,100 | $22.97 | $484,561.50 |
DisclosureSEC source: 0000009389-21-000106 · edgar.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · E.V.P. and C.F.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,607.0751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common stock acquired upon the exercise of Stock Appreciation Rights (SARS). F2 · ownership.direct: The securities included herein represent only those securities that are required to be disclosed pursuant to Section 16(a) of the Securities Exchange Act of 1934 in connection with the specific transaction(s) reported herein. The reporting person is the beneficial owner of additional shares and/or derivative securities of the issuer that are not disclosed on this Form 4. For additional information regarding the reporting person's ownership of issuer securities, refer to Forms 4 previously filed by the reporting person and the Compensation Discussion & Analysis section of the issuer's 2021 Proxy Statement. Read SEC document |
| April 22, 2021 Filed Apr 26, 2021 21:04 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantCommon Stock | 1,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014457 · form4.xml · nonDerivative · entry 1 MORRISON SCOTT C · CIK 0001205945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,550.409 F1 · kind: Represents grant of restricted stock under Issuer's 2012 Non-Employee Directors Stock Plan. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.